November 28, 2012 / 9:37 PM / 5 years ago

BRIEF-FDA advisory panel backs J&J drug for multidrug-resistant TB

Nov 28 (Reuters) - Johnson & Johnson : * FDA advisory panel, by 18 to 0 vote, says data supports efficacy of j&j

drug bedaquiline against multidrug-resistant tb - j&j * FDA advisory panel, by 11 to 7 vote, say data suggest safety of bedaquiline

tb drug - j&j

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below